LEO Pharma is expanding upon its ambitions in the United States (U.S.) as the FDA has accepted for filing the company’s New Drug Application (NDA) for delgocitinib cream, an investigational innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results